First Time Loading...

Biomerieux SA
PAR:BIM

Watchlist Manager
Biomerieux SA Logo
Biomerieux SA
PAR:BIM
Watchlist
Price: 95.9 EUR -0.1%
Updated: May 20, 2024

Biomerieux SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biomerieux SA
Revenue Peer Comparison

Comparables:
EDAP
ALCAR
ALVMG
ALCOR
AMPLI

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Biomerieux SA
PAR:BIM
Revenue
€3.7B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
9%
Edap Tms SA
NASDAQ:EDAP
Revenue
€60.4m
CAGR 3-Years
13%
CAGR 5-Years
9%
CAGR 10-Years
10%
Carmat SA
PAR:ALCAR
Revenue
€2.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Visiomed Group SA
PAR:ALVMG
Revenue
€13.7m
CAGR 3-Years
-10%
CAGR 5-Years
9%
CAGR 10-Years
2%
Biocorp Production SA
PAR:ALCOR
Revenue
€11.7m
CAGR 3-Years
11%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Amplitude Surgical SA
PAR:AMPLI
Revenue
€104m
CAGR 3-Years
7%
CAGR 5-Years
0%
CAGR 10-Years
N/A

See Also

What is Biomerieux SA's Revenue?
Revenue
3.7B EUR

Based on the financial report for Dec 31, 2023, Biomerieux SA's Revenue amounts to 3.7B EUR.

What is Biomerieux SA's Revenue growth rate?
Revenue CAGR 10Y
9%

Over the last year, the Revenue growth was 2%. The average annual Revenue growth rates for Biomerieux SA have been 6% over the past three years , 9% over the past five years , and 9% over the past ten years .